Efficacy and safety of (177)Lutetium-prostate-specific membrane antigen therapy in metastatic castration-resistant prostate cancer patients: First experience in West Asia – A prospective study

Prostate-specific membrane antigen (PSMA) is a transmembrane protein that is highly expressed on the surface of prostate cancer (PC) cells, making it an excellent radiotracer for both therapeutic and diagnostic purposes. In this prospective study, we investigated the efficacy and toxicity of (177)Lu...

Descripción completa

Detalles Bibliográficos
Autores principales: Aghdam, Ramin Akbarian, Amoui, Mahasti, Ghodsirad, Mohammadali, Khoshbakht, Sepide, Mofid, Bahram, Kaghazchi, Fateme, Tavakoli, Mehrdad, Pirayesh, Elahe, Ahmadzadehfar, Hojjat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714159/
https://www.ncbi.nlm.nih.gov/pubmed/31516369
http://dx.doi.org/10.4103/wjnm.WJNM_66_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714159/
https://www.ncbi.nlm.nih.gov/pubmed/31516369
http://dx.doi.org/10.4103/wjnm.WJNM_66_18

Ejemplares similares